Drug stability studies. Why are they important?

What is required to file a drug patent application?

The innovation that comes from the University

Biological and biosimilar medicines - development and commercialization challenges

What was the impact of the pandemic on clinical studies?

What are the main differences between the ICH guides and the ANVISA requirements?

Access to post-study medicines: status in Brazil and challenges yet to be overcome.

Pharmaceutical Industry – focused on the future

Descentralized clinical studies

The economic impact of the new health technologies

ANVISA – Post-pandemic challenges and perspectives.

What is the purpose of registration submission guide, based on data from scientific literature?

Clinical research in Brazil - regulation is important and urgent!

Psychedelic Drugs - New Opportunities for the Pharmaceutical Market.

Clinical research in Brazil – New horizons, new challenges

ANVISA has just published the new version of the Cadifa Manual, but what were the main changes?

Medicine patents in Brazil – legislative changes and their impacts.

Brazilian regulation prices, and future trends

Innovation - The Driving Force of the Pharmaceutical Industry

Covid 19 vaccines - know the difference between them